|
1
|
Shields CL and Shields JA: Retinoblastoma
management: Advances in enucleation, intravenous chemoreduction,
and intra-arterial chemotherapy. Curr Opin Ophthalmol. 21:203–212.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jabbour P, Chalouhi N, Tjoumakaris S,
Gonzalez LF, Dumont AS, Chitale R, Rosenwasser R, Bianciotto CG and
Shields C: Pearls and pitfalls of intraarterial chemotherapy for
retinoblastoma. J Neurosurg Pediatr. 10:175–181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Houston SK, Murray TG, Wolfe SQ and
Fernandes CE: Current update on retinoblastoma. Int Ophthalmol
Clin. 51:77–91. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kivelä T: The epidemiological challenge of
the most frequent eye cancer: Retinoblastoma, an issue of birth and
death. Br J Ophthalmol. 93:1129–1131. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Du T and Zamore PD: Beginning to
understand microRNA function. Cell Res. 17:661–663. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brennecke J, Hipfner DR, Stark A, Russell
RB and Cohen SM: bantam encodes a developmentally regulated
microRNA that controls cell proliferation and regulates the
proapoptotic gene hid in Drosophila. Cell. 113:25–36. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Geng S and Zhou W: Influence of extrinsic
inputs and synaptic gains on dynamics of Wendling's neural mass
model: A bifurcation analysis. J Integr Neurosci. 15:463–483. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu P, Vernooy SY, Guo M and Hay BA: The
Drosophila microRNA Mir-14 suppresses cell death and is required
for normal fat metabolism. Curr Biol. 13:790–795. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang W, Bai J, Liu D, Wang S, Zhao N, Che
R and Zhang H: MiR-93-5p up-regulation is involved in non-small
cell lung cancer cells proliferation and migration and poor
prognosis. Gene. 647:13–20. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu S, Zhang X, Hu C, Wang Y and Xu C:
miR-29a inhibits human retinoblastoma progression by targeting
STAT3. Oncol Rep. 39:739–746. 2018.PubMed/NCBI
|
|
13
|
Yang G, Fu Y, Zhang L, Lu X and Li Q:
miR106b regulates retinoblastoma Y79 cells through Runx3. Oncol
Rep. 38:3039–3043. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen Y, Ye YF, Ruan LW, Bao L, Wu MW and
Zhou Y: Inhibition of miR-660-5p expression suppresses tumor
development and metastasis in human breast cancer. Genet Mol Res.
16:2017. View Article : Google Scholar
|
|
15
|
Xie F, Yuan Y, Xie L, Ran P, Xiang X,
Huang Q, Qi G, Guo X, Xiao C and Zheng S: miRNA-320a inhibits tumor
proliferation and invasion by targeting c-Myc in human
hepatocellular carcinoma. Onco Targets Ther. 10:885–894. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song D, Diao J, Yang Y and Chen Y:
MicroRNA382 inhibits cell proliferation and invasion of
retinoblastoma by targeting BDNF-mediated PI3K/AKT signalling
pathway. Mol Med Rep. 16:6428–6436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Y, Zhang S and Zhang Y: MicroRNA-320
inhibits cell proliferation, migration and invasion in
retinoblastoma by targeting specificity protein 1. Mol Med Rep.
16:2191–2198. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Liao Z, Bai Z, He Y, Duan J and
Wei L: MiR-93-5p promotes cell proliferation through
down-regulating PPARGC1A in hepatocellular carcinoma cells by
bioinformatics analysis and experimental verification. Genes
(Basel). 9:E512018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li L, Zhao J, Huang S, Wang Y, Zhu L, Cao
Y, Xiong J and Deng J: MiR-93-5p promotes gastric cancer-cell
progression via inactivation of the Hippo signaling pathway. Gene.
641:240–247. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Waniczek D, Śnietura M, Lorenc Z,
Nowakowska-Zajdel E and Muc-Wierzgoń M: Assessment of PI3K/AKT/PTEN
signaling pathway activity in colorectal cancer using quantum
dot-conjugated antibodies. Oncol Lett. 15:1236–1240.
2018.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Di Fiore R, Drago-Ferrante R, D'Anneo A,
Augello G, Carlisi D, De Blasio A, Giuliano M, Tesoriere G and
Vento R: In human retinoblastoma Y79 cells okadaic
acid-parthenolide co-treatment induces synergistic apoptotic
effects, with PTEN as a key player. Cancer Biol Ther. 14:922–931.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Y and Mei Q: miRNA signature
identification of retinoblastoma and the correlations between
differentially expressed miRNAs during retinoblastoma progression.
Mol Vis. 21:1307–1317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu S, Hu C, Wang Y, Shi G, Li Y and Wu H:
miR-124 inhibits proliferation and invasion of human retinoblastoma
cells by targeting STAT3. Oncol Rep. 36:2398–2404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lei Q, Shen F, Wu J, Zhang W, Wang J and
Zhang L: MiR-101, downregulated in retinoblastoma, functions as a
tumor suppressor in human retinoblastoma cells by targeting EZH2.
Oncol Rep. 32:261–269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu K, Huang J, Xie M, et al: MIR34A
regulates autophagy and apoptosis by targeting HMGB1 in the
retinoblastoma cell. Autophagy. 10:442–452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang J, Wang X, Li Z, Liu H and Teng Y:
MicroRNA-183 suppresses retinoblastoma cell growth, invasion and
migration by targeting LRP6. FEBS J. 281:1355–1365. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Martin A, Jones A, Bryar PJ, et al:
MicroRNAs-449a and −449b exhibit tumor suppressive effects in
retinoblastoma. Biochem Biophys Res Commun. 440:599–603. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Wang X, Wu G, Hou D and Hu Q:
MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle
progression and apoptosis of human retinoblastoma cells by
targeting PAX6. FEBS Lett. 587:1779–1786. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen X, Chen S, Xiu YL, Sun KX, Zong ZH
and Zhao Y: RhoC is a major target of microRNA-93-5P in epithelial
ovarian carcinoma tumorigenesis and progression. Mol Cancer.
14:312015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen S, Chen X, Sun KX, Xiu YL, Liu BL,
Feng MX, Sang XB and Zhao Y: MicroRNA-93 promotes
epithelial-mesenchymal transition of endometrial carcinoma cells.
PLoS One. 11:e01657762016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shyamasundar S, Lim JP and Bay BH: miR-93
inhibits the invasive potential of triple-negative breast cancer
cells in vitro via protein kinase WNK1. Int J Oncol. 49:2629–2636.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ivkovic Catela T, Voss G, Cornella H and
Ceder Y: microRNAs as cancer therapeutics: A step closer to
clinical application. Cancer Lett. 407:113–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wei D, Miao Y, Yu L, Wang D and Wang Y:
Downregulation of microRNA198 suppresses cell proliferation and
invasion in retinoblastoma by directly targeting PTEN. Mol Med Rep.
18:595–602. 2018.PubMed/NCBI
|
